Skip to content

Inhaled 5-methoxy-N,N-dimethyltryptamine: Supportive context associated with positive acute and enduring effects

Nathan D. Sepeda, John Clifton, Laura Y. Doyle, Rafael Lancelotta, Roland R. Griffiths, Alan K. Davis

Journal of Psychedelic Studies December 27, 2019 DOI: 10.1556/2054.2019.033 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional survey Peer reviewed
Sample size 578
Population Adults who used inhaled synthetic 5-MeO-DMT
Intervention inhaled synthetic 5-MeO-DMT
Topics 5-MeO-DMT Altered states of consciousness DMT
Keywords Psychedelic experience Psychedelic journey Consciousness exploration Profound experience 5-MEO-DMT Experience Set and setting Supportive setting Structured setting Therapeutic environment Psychedelic setting 5-MEO-DMT Context 5-MEO-DMT Research 5-MEO-DMT Study Psychedelic research Psychedelic compound Toad medicine Psychedelic benefits Therapeutic effects Positive outcomes Well-being Spiritual growth Personal growth Mystical experiences Meaning Spirituality Lasting effects
Citations 23
Key findings A structured, supportive context for 5-MeO-DMT use was associated with higher rates of mystical experiences and greater enduring positive effects, and with fewer challenging experiences, compared to a non-structured context.

Abstract

Background and aims 5-Methoxy- N,N -dimethyltryptamine (5-MeO-DMT) is a potent, short-acting psychedelic that produces strong hallucinogenic effects. The association between the context (i.e., set and setting) of 5-MeO-DMT use and the acute and enduring effects of the substance is unknown. Therefore, this study examined these associations using secondary data from two cross-sectional survey studies.

Methods: The acute and enduring effects of inhaled synthetic 5-MeO-DMT were compared between individuals who used 5-MeO-DMT in a non-structured context (NSC; n = 216, female = 10%, M age = 35.5, SD = 11.8) and those who used in a structured context (SC; n = 362, female = 45%, M age = 47.7, SD = 13.3). Questionnaires were administered online and responses were anonymized for privacy purposes. Respondents were asked to retrospectively rate their first experience with synthesized 5-MeO-DMT on measures of mystical experience, challenging experience, and enduring effects.

Results: Both groups endorsed high ratings on the Mystical Experience Questionnaire; however, mean scores were significantly higher in the SC group compared to the NSC group. Similarly, the proportion of respondents who had a complete mystical experience was significantly larger in the SC group (83%) compared to the NSC group (54%). Ratings of enduring effects (i.e., meaningfulness, spirituality, and well-being) were also significantly higher, and the intensity of challenging experiences was significantly lower, in the SC group compared to the NSC group.

Conclusions: 5-MeO-DMT appears to occasion mystical-type experiences with enduring positive effects, which are more intense when 5-MeO-DMT is administered in a safe and supportive context. Future prospective experimental studies should examine the effects of 5-MeO-DMT and its interactive relationship with supportive contextual factors.

Comparable studies

Other cross-sectional and survey studies on 5-MeO-DMT, most cited first.

Study Year Design Participants
Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. People who had a memorable entity encounter after taking N,N-dimethyltryptamine 2020 Survey n = 2,561
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. Adults who used 5-MeO-DMT in a group setting with structured procedures 2019 Cross-sectional survey n = 362
The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. Adults who use 5-MeO-DMT, recruited via internet-based advertisements; predominantly... 2018 Cross-sectional survey n = 515
Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects 5-MeO-DMT users 2020 Cross-sectional survey n = 515
Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence People who used 5-MeO-DMT in non-clinical settings 2022 Observational cross-sectional survey n = 513

Citations in the library

Cited by 24

and 19 more in the library

Cites 32

and 27 more in the library

Explore topics